These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 8840871)
1. Postischemic antiarrhythmic effects of angiotensin-converting enzyme inhibitors. Role of suppression of endogenous endothelin secretion. Brunner F; Kukovetz WR Circulation; 1996 Oct; 94(7):1752-61. PubMed ID: 8840871 [TBL] [Abstract][Full Text] [Related]
2. Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats. Liu YH; Yang XP; Sharov VG; Sigmon DH; Sabbath HN; Carretero OA Hypertension; 1996 Jan; 27(1):7-13. PubMed ID: 8591891 [TBL] [Abstract][Full Text] [Related]
3. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors. Hartman JC Ann Thorac Surg; 1995 Sep; 60(3):789-92. PubMed ID: 7545893 [TBL] [Abstract][Full Text] [Related]
4. Cardiac arrhythmias are ameliorated by local inhibition of angiotensin formation and bradykinin degradation with the converting-enzyme inhibitor ramipril. Linz W; Schölkens BA; Kaiser J; Just M; Qi BY; Albus U; Petry P Cardiovasc Drugs Ther; 1989 Dec; 3(6):873-82. PubMed ID: 2535056 [TBL] [Abstract][Full Text] [Related]
5. Local inhibition of bradykinin degradation in ischemic hearts. Linz W; Martorana PA; Schölkens BA J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S99-109. PubMed ID: 1697370 [TBL] [Abstract][Full Text] [Related]
6. Cardioprotection with angiotensin converting enzyme inhibitor and angiotensin II type 1 receptor antagonist is not abolished by nitric oxide synthase inhibitor in ischemia-reperfused rabbit hearts. Kawabata H; Ryomoto T; Ishikawa K Hypertens Res; 2001 Jul; 24(4):403-9. PubMed ID: 11510753 [TBL] [Abstract][Full Text] [Related]
7. Attenuation of reperfusion arrhythmias by selective inhibition of angiotensin-converting enzyme/kininase II in the ischemic zone: mediated by endogenous bradykinin? Shimada Y; Avkiran M J Cardiovasc Pharmacol; 1996 Mar; 27(3):428-38. PubMed ID: 8907806 [TBL] [Abstract][Full Text] [Related]
8. Cardioprotective effects of the aminopeptidase P inhibitor apstatin: studies on ischemia/reperfusion injury in the isolated rat heart. Erşahin C; Euler DE; Simmons WH J Cardiovasc Pharmacol; 1999 Oct; 34(4):604-11. PubMed ID: 10511138 [TBL] [Abstract][Full Text] [Related]
9. Role of kinins in the pathophysiology of myocardial ischemia. In vitro and in vivo studies. Linz W; Wiemer G; Schölkens BA Diabetes; 1996 Jan; 45 Suppl 1():S51-8. PubMed ID: 8529801 [TBL] [Abstract][Full Text] [Related]
10. Synergy of amlodipine and angiotensin-converting enzyme inhibitors in regulating myocardial oxygen consumption in normal canine and failing human hearts. Mital S; Loke KE; Slater JP; Addonizio L; Gersony WM; Hintze TH Am J Cardiol; 1999 Jun; 83(12A):92H-98H. PubMed ID: 10750596 [TBL] [Abstract][Full Text] [Related]
11. Attenuation of myocardial stunning by the ACE inhibitor ramiprilat through a signal cascade of bradykinin and prostaglandins but not nitric oxide. Ehring T; Baumgart D; Krajcar M; Hümmelgen M; Kompa S; Heusch G Circulation; 1994 Sep; 90(3):1368-85. PubMed ID: 8087948 [TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers synergistically increase coronary blood flow in canine ischemic myocardium: role of bradykinin. Kitakaze M; Asanuma H; Funaya H; Node K; Takashima S; Sanada S; Asakura M; Ogita H; Kim J; Hori M J Am Coll Cardiol; 2002 Jul; 40(1):162-6. PubMed ID: 12103271 [TBL] [Abstract][Full Text] [Related]
14. Influence of local converting enzyme inhibition on angiotensin and bradykinin effects in ischemic rat hearts. Linz W; Schölkens BA J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S75-82. PubMed ID: 2485067 [TBL] [Abstract][Full Text] [Related]
15. Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat. Wollert KC; Studer R; Doerfer K; Schieffer E; Holubarsch C; Just H; Drexler H Circulation; 1997 Apr; 95(7):1910-7. PubMed ID: 9107180 [TBL] [Abstract][Full Text] [Related]
16. Reperfusion-induced arrhythmias are suppressed by inhibition of the angiotensin II type 1 receptor. Yahiro E; Ideishi M; Wang LX; Urata H; Kumagai K; Arakawa K; Saku K Cardiology; 2003; 99(2):61-7. PubMed ID: 12711879 [TBL] [Abstract][Full Text] [Related]
17. Bradykinin-dependent cardioprotective effects of losartan against ischemia and reperfusion in rat hearts. Zhu P; Zaugg CE; Hornstein PS; Allegrini PR; Buser PT J Cardiovasc Pharmacol; 1999 May; 33(5):785-90. PubMed ID: 10226867 [TBL] [Abstract][Full Text] [Related]
18. ACE-inhibition induces NO-formation in cultured bovine endothelial cells and protects isolated ischemic rat hearts. Linz W; Wiemer G; Schölkens BA J Mol Cell Cardiol; 1992 Aug; 24(8):909-19. PubMed ID: 1331474 [TBL] [Abstract][Full Text] [Related]
19. Cardioprotective effect of angiotensin-converting enzyme inhibition against hypoxia/reoxygenation injury in cultured rat cardiac myocytes. Matoba S; Tatsumi T; Keira N; Kawahara A; Akashi K; Kobara M; Asayama J; Nakagawa M Circulation; 1999 Feb; 99(6):817-22. PubMed ID: 9989969 [TBL] [Abstract][Full Text] [Related]
20. Comparative effects of pretreatment with captopril and losartan on cardiovascular protection in a rat model of ischemia-reperfusion. Zhu B; Sun Y; Sievers RE; Browne AE; Pulukurthy S; Sudhir K; Lee RJ; Chou TM; Chatterjee K; Parmley WW J Am Coll Cardiol; 2000 Mar; 35(3):787-95. PubMed ID: 10716484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]